《大行報告》里昂:中資科網股明年首選騰訊、美團、阿里及京東健康等
里昂發表研究報告指,年初至今中國科網板塊表現(跌18%)跑贏MSCI中國指數和納指(跌27%),雖然行業仍面對宏觀困境,但企業盈利於今年第二季見底並強勁反彈,第三季按年增長44%,預期第四季將繼續實現按年增長。
考慮到估值壓力及成本優化,該行認為中國互聯網行業是中國經濟重啟中的最佳選擇,相信隨著防疫措施放寬,電商收入增長將最明顯快,料旅遊增40%、本地服務增25%及實體商品增13%,海外遊戲將會是另一催化劑,而廣告則相對落後。
里昂2023年首選為騰訊(00700.HK)、美團(03690.HK)、阿里巴巴(09988.HK)(BABA.US)、攜程(09961.HK)(TCOM.US)及京東健康(06618.HK),憧憬明年監管和宏觀環境將更加有利,其中當局已恢復每月新遊戲版號審批,並表示對互聯網平台整改感到滿意。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.